{"id":"clm_94C2592AE159","entity":"abbott-laboratories","predicate":"quarterly_operating_income","value":"2,057,000,000 United States dollar","value_json":{"fp":"Q3","fy":2025,"accn":"0001628280-25-047131","form":"10-Q","filed":"2025-10-29","period":"Q3 FY2025","concept":"us-gaap:OperatingIncomeLoss"},"valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Abbott Laboratories quarterly operating income: 2,057,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_94C2592AE159, https://asof.is/claim/clm_94C2592AE159, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/0001628280-25-047131-index.htm.","url":"https://asof.is/claim/clm_94C2592AE159","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1C0A2724D779","supersedes":["clm_D4D65248DFB6"],"first_seen_at":"2026-11-08T16:56:09.404533+00:00","updated_at":"2026-11-08T16:56:16.878388+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/0001628280-25-047131-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2025, filed 2025-10-29"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}